Triple
T22796749
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CDK6 |
E564269
|
entity |
| Predicate | encodes |
P14248
|
FINISHED |
| Object | cyclin-dependent kinase 6 |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: cyclin-dependent kinase 6 | Statement: [CDK6, encodes, cyclin-dependent kinase 6]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: cyclin-dependent kinase 6 Context triple: [CDK6, encodes, cyclin-dependent kinase 6]
-
A.
CDK6
chosen
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
B.
cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
-
C.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
D.
CDK7 kinase
CDK7 kinase is a cyclin-dependent kinase that functions as a key regulator of transcription initiation and cell cycle control by phosphorylating the C-terminal domain of RNA polymerase II and activating other CDKs.
-
E.
CDK9 kinase
CDK9 kinase is a cyclin-dependent protein kinase that forms part of the P-TEFb complex and promotes transcription elongation by phosphorylating the C-terminal domain of RNA polymerase II.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2458185f88190b0045227ee420411 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17cd9b3c0819096050f43a829ec0d |
completed | April 29, 2026, 3:36 a.m. |
Created at: April 17, 2026, 3:30 p.m.